Comparison between Om Metallogic IPO and Sheel Biotech IPO.
Om Metallogic IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Sheel Biotech IPO is a SME Bookbuilding proposed to list at NSE SME.
| Om Metallogic IPO | Sheel Biotech IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Corporate Makers Capital Ltd. | Narnolia Financial Services Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Prabhat Financial Services Ltd. | Mansi Share & Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Om Metallogic IPO is up to ₹21.22 Cr whereas the issue size of the Sheel Biotech IPO is up to ₹32.31 Cr. The final issue price of Om Metallogic IPO is ₹86.00 per share and of Sheel Biotech IPO is ₹63.00 per share.
| Om Metallogic IPO | Sheel Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹59.00 per share | |
| Issue Price (Upper) | ₹63.00 per share | |
| Issue Price (Final) | ₹86.00 per share | ₹63.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 2000 shares |
| Fresh Issue Size | 24,67,200 shares | 51,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹21.22 Cr | up to ₹32.31 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 24,67,200 shares | 51,28,000 shares |
| Issue Size Total (Amount) | up to ₹21.22 Cr | up to ₹32.31 Cr |
Om Metallogic IPO opens on Sep 29, 2025, while Sheel Biotech IPO opens on Sep 30, 2025. The closing date of Om Metallogic IPO and Sheel Biotech IPO is Oct 01, 2025, and Oct 03, 2025, respectively.
| Om Metallogic IPO | Sheel Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Sep 29, 2025 | |
| Issue Open | Sep 29, 2025 | Sep 30, 2025 |
| Issue Close | Oct 01, 2025 | Oct 03, 2025 |
| Basis Of Allotment (Tentative) | Oct 03, 2025 | Oct 06, 2025 |
| Initiation of Refunds (Tentative) | Oct 06, 2025 | Oct 07, 2025 |
| Credit of Share (Tentative) | Oct 06, 2025 | Oct 07, 2025 |
| Listing date (Tentative) | Oct 07, 2025 | Oct 08, 2025 |
| Anchor Lockin End date 1 | Nov 05, 2025 | |
| Anchor Lockin End date 2 | Jan 04, 2026 |
Om Metallogic IPO P/E ratio is 10.99, as compared to Sheel Biotech IPO P/E ratio of 8.86.
| Om Metallogic IPO | Sheel Biotech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Om Metallogic Ltd.'s revenue increased by 55% and profit after tax (PAT) rose by 86% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Sheel Biotech Ltd.'s revenue increased by 11% and profit after tax (PAT) rose by 2% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 88.51 | 96.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 59.26 | 71.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 10.99 | 8.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹67.62 Cr. | ₹128.22 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 42.37 | 13.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 55.50 | 16.34 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.88 | 0.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.82 | ₹7.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 34.96 | 13.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Om Metallogic IPO Retail Individual Investors (RII) are offered 12,33,600 shares while in Sheel Biotech IPO retail investors are offered 12,33,600 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Om Metallogic IPO and 10,26,000 shares in Sheel Biotech IPO.
| Om Metallogic IPO | Sheel Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 15,24,000 shares |
| Market Maker Reservation | 1,31,200 shares | 2,72,000 shares |
| QIB | 0 shares | 10,26,000 shares |
| NII | 12,33,600 shares | 7,74,000 shares |
| RII | 12,33,600 shares | 18,04,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 24,67,200 shares | 51,28,000 shares |
Om Metallogic IPO subscribed 1.47x in total, whereas Sheel Biotech IPO subscribed 15.97x.
| Om Metallogic IPO | Sheel Biotech IPO | |
|---|---|---|
| QIB (times) | 19.73x | |
| NII (times) | 0.41x | 25.92x |
| Big NII (times) | 31.64x | |
| Small NII (times) | 14.49x | |
| RII (times) | 2.53x | 9.56x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.47x | 15.97x |
